or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
drug PhD Projects, Programmes & Scholarships
We have 326 drug PhD Projects, Programmes & Scholarships
Immunogenic response to anti-TNF therapeutics: defining the role of protein glycosylation
Commercial partner: Ludger Ltd. Anti-TNF therapies, in use for over 20 years in inflammatory bowel disease (IBD) management, continue to be widely regarded as first-line biological therapy in Crohn’s disease. Read more
Non-invasive Therapy for Soft Tissue Reconstruction: Applications in Cosmetics and Wound Healing
Soft tissue reconstruction is emerging as an important strategy to repair and replace diseased or damaged tissue that has been compromised due to tumour removal, injury, trauma, ageing, etc. Read more
Enzyme-responsive peptide hydrogels as in situ forming long-acting drug delivery implants
One of the key issues in the treatment and prevention of disease is that patients struggle to adhere to the complex dosage regimens of therapies, which often require multiple dosing at very specific times each day. Read more
Nanotechnologies for cancer: developing new polymer-drug conjugates for the treatment of a range of cancers
Polymer anticancer-drug conjugates are drug delivery systems in which a low molecular weight anticancer agent is covalently conjugated to a water-soluble polymeric carrier. Read more
Developing and testing novel methods to estimate prevalence of methamphetamine and cocaine dependence
Drug-related harm from illegal supplies of drugs is changing, including a rise in deaths associated with stimulants in many countries. Read more
Mechanistic design of effective pharmaceutical cocrystal formulations
It is estimated that more than 70 percent of the compounds in the pharmaceutical pipeline can be poorly water-soluble. Since solid drug forms must dissolve before absorption can occur, strategies to improve drug solubility and dissolution are a continuous need. Read more
Developing a novel drug screening platform for schistosomes using the free-living flatworm Schmidtea mediterranea
Schistosoma mansoni is one of three major schistosome species that infect over 240 million people across 70 developing countries, with an additional 0.6 billion at risk of infection. Read more
MSc by Research: Clustering the protein universe across the Tree of Life to enhance drug discovery
Drug discovery is the systematic process of identifying and optimizing molecular compounds to develop targeted medications for medical conditions. Read more
PhD in Chemistry: Design, synthesis and biological evaluation of molecules to tackle invasive fungal infections
Fungal infections are a major threat to public health as they are becoming increasingly resistant to treatment. Only four classes of antifungals are available, with few candidates in the clinical pipeline. Read more
Endosomal Sorting Complex Required for Transport (ESCRT): Investigation of the role in acquired drug resistance in colon cancer
Research Group:
Institute of Cancer Therapeutics
Despite treatment advances, one of the most common cancers, colorectal cancer (CRC), still has a 45% mortality rate, and one of the major problems is the build-up of resistance to cancer drugs during treatment (‘acquired resistance’) such that over time the drugs stop working. Read more
Advancing Drug Delivery and Gene Therapy for Regeneration and Repair of the Aging Cartilage (NDORMS-2025/12)
Drugs targeting biological drivers of aging face unique translational challenges. Read more
Novel design and formulation strategies to enhance drug delivery
The main research activities of my research group concern the improvement of traditional drug formulation and development of novel drug and formulation strategies to enhance bioavailability and patient acceptability. Read more
Pharmacovigilance and Polypharmacology: Identification of differential side effects within drug classes and links to their unique modes of action
The aim of this study is to determine the differences and potential mechanistic rationale for observed adverse drug reactions (ADRs) in a series of related drug classes. Read more
Development of novel macrophage high-throughput cell-based phenotypic assay for drug screening
Research Group:
Biomedical Research Group
Research Group. Biomedical Research Group. Proposed supervisory team. Dr Grisha Pirianov. . Prof David Leake (University of Reading). Read more